logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
International Journal of Cancer 封面图

International Journal of Cancer

IF4.7
论文数22257
被引数49425
期刊论文 22257
发表时间
delete
Reply to: Comments on ‘Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer’回复：《质子泵抑制剂与辅助化疗期间患者生存结局在III期结直肠癌患者中的联合使用》的评论
deleteInternational Journal of Cancer
IF4.7
delete2026-10-28
delete0
PREAI
deleteMatthew Loft; Peter Gibbs
delete分享
delete收藏
Comments on “Concomitant Use of Proton Pump Inhibitors and Survival Outcomes in Patients Receiving Adjuvant Chemotherapy for Stage III Colon Cancer”对“接受辅助化疗的III期结肠癌患者中质子泵抑制剂与生存结局的合并使用”的评论
deleteInternational Journal of Cancer
IF4.7
delete2026-10-28
delete0
PREAI
deleteXiaoxiang Zhang; Yu Zhang
delete分享
delete收藏
Epigenetic Predictors of Smoking: External Validation and Association With Smoking-Related Cancer Risk吸烟的表观遗传预测因子：外部验证及其与吸烟相关癌症风险的关联
deleteInternational Journal of Cancer
IF4.7
delete2026-10-21
delete0
deleteOAAI
deleteXiaoyu Fan; Danmeng Lily Li; Allison M. Hodge; Julie K. Bassett; Nina Afshar; Melissa C. Southey; Graham G. Giles; Roger L. Milne; Pierre-Antoine Dugué
delete分享
delete收藏
MLH1 p.His112Arg Variant Is Associated With Increased Cancer SusceptibilityMLH1 p.His112Arg变异与癌症易感性的增加相关
deleteInternational Journal of Cancer
IF4.7
delete2026-10-21
delete0
deleteOAAI
deleteAmal Elfatih; Issam Tout; Najwa Ahmad Doha; Tala Abu Arja; Idris Mohammed; Doua Abdelrhaman; Waseem Hasan; Chadi Saad; Hamdi Mbarek; Borbala Mifsud; Sahar Isa Da'as
delete分享
delete收藏
Outcomes Following Pancreatoduodenectomy With Arterial Resection: A NSQIP Analysis Comparing Trends in Patient Selection and Outcomes to Venous or no Vascular Resection Over 5 Years动脉切除的胰十二指肠切除术后结局：一项NSQIP分析，比较5年内患者选择和结局与静脉切除或无血管切除的趋势
deleteInternational Journal of Cancer
IF4.7
delete2026-10-21
delete0
deleteOAAI
deleteKevin Verhoeff; Alynne Kris Ribano; Daniel Kilburn; Carol-Anne Moulton; Chaya Shwaartz; Trevor Reichman; Ian McGlivray; Sean Cleary
delete分享
delete收藏
Incidence and Predictors of Immune-Related Hypothyroidism Under Pembrolizumab Across Gynecologic Malignancies and Melanoma: A Real-World Cohort Study免疫相关甲状腺功能减退症在帕博利珠单抗治疗妇科恶性肿瘤和黑色素瘤中的发生率及预测因素：一项真实世界队列研究
deleteInternational Journal of Cancer
IF4.7
delete2026-10-21
delete0
deleteOAAI
deleteFreya Koffka; Johann Kornowski; Elena Laakmann; Barbara Schmalfeldt; Tim Zell; Glenn Geidel; Christoffer Gebhardt; Pia Roser; Volkmar Müller; Julian Kött
delete分享
delete收藏
Activity of Low Dose Nivolumab in Patients With Advanced Squamous Cell Carcinomas and Other Cancers低剂量纳武利尤单抗在晚期鳞状细胞癌及其他癌症患者中的活性
deleteInternational Journal of Cancer
IF4.7
delete2026-10-20
delete0
PREAI
deleteThibault Gauduchon; Jerome Fayette; Mona Amini‐Adle; Eve‐Marie Neidhart‐Berard; Mehdi Brahmi; Armelle Dufresne; Margaux Dupont; Clelia Coutzac; Axel de Bernardi; Philippe Toussaint; Benoite Mery; Laura Crumbach; Isabelle Ray‐Coquard; Aurélie Dutour; Marie Castets; Jean‐Yves Blay; Pierre Etienne Heudel
delete分享
delete收藏
Tumour Antigen‐Specific Antibody Signatures as Diagnostic Biomarkers for Melanoma肿瘤抗原特异性抗体特征作为黑色素瘤的诊断生物标志物
deleteInternational Journal of Cancer
IF4.7
delete2026-10-20
delete0
PREAI
deleteCristina Vico‐Alonso; Tawany De Carvalho Gil; Maithili Sashindranath; Victoria Mar; Jessica Da Gama Duarte
delete分享
delete收藏
From Intestinal Origins to Mammary Targets: Exploring the Potential Role of the Brain‐Gut‐Microbiota Axis in Pre‐Metastatic Conditioning of Breast Tissue in Colorectal Cancer从肠道起源到乳腺靶点：探索脑-肠-微生物轴在结直肠癌中乳腺癌前转移微环境形成中的潜在作用
deleteInternational Journal of Cancer
IF4.7
delete2026-10-20
delete0
PREAI
deleteYu Chen; Dong Tang
delete分享
delete收藏
BRCAness ‐Driven Prognostic Model and Regimen‐Specific Therapeutic Implications in Triple‐Negative Breast Cancer With Residual Disease After Neoadjuvant ChemotherapyBRCAness驱动的预后模型及特定治疗方案在经新辅助化疗后仍有残留病灶的三阴性乳腺癌中的治疗意义
deleteInternational Journal of Cancer
IF4.7
delete2026-10-17
delete0
PREAI
deleteHangcheng Xu; Yan Wang; Qiang Sa; Yiran Zhou; Fei Ma; Ying Fan; Pin Zhang; Qing Li; Qiao Li; Yang Luo; Ruigang Cai; Hongnan Mo; Bo Lan; Jiani Wang; Shanshan Chen; Jiayu Wang; Binghe Xu
delete分享
delete收藏
Epstein–Barr Virus Association and Prognosis in Taiwanese Hodgkin Lymphoma: A Nationwide Multicenter Study With Comparison to United States Whites台湾霍奇金淋巴瘤中EB病毒的关联性与预后：一项与美籍白人对比的全国多中心研究
deleteInternational Journal of Cancer
IF4.7
delete2026-10-17
delete0
deleteOAAI
deleteShu‐Hsien Wang; Chang‐Tsu Yuan; Chun‐Ju Chiang; Ren‐Ching Wang; Wen‐Chung Lee; Hsin‐Ni Li; Sheau‐Fang Yang; Bo‐Jung Chen; Yen‐Lin Huang; Yi‐Jen Peng; Ching‐Fen Yang; Jie‐Yang Jhuang; Wan‐Ru Chao; Yen‐Chang Chen; L. Jeffery Medeiros; Kung‐Chao Chang
delete分享
delete收藏
Cancer in the Oldest‐Old in Super‐Aging Japan: Trends and Characteristics From National Registry Data日本超长寿人群中极高龄老年人的癌症：基于国家登记数据的趋势和特征
deleteInternational Journal of Cancer
IF4.7
delete2026-10-15
delete0
deleteOAAI
deleteSayo Tanaka; Hirokazu Tanaka; Kota Katanoda
delete分享
delete收藏
Controlled Trial of Cervical Cancer Screening Frequency Among Human Papillomavirus Vaccinated Women II : Cervical Pre‐Cancer End‐Points by Specific Non‐Vaccine HPV Types人乳头瘤病毒疫苗接种女性中宫颈癌筛查频率的对照试验（II）：特定非疫苗人乳头瘤病毒类型的宫颈癌前病变终点
deleteInternational Journal of Cancer
IF4.7
delete2026-10-15
delete0
deleteOAAI
deleteMatti Lehtinen; Mònica Ortega Llobet; Tiina Eriksson; Iacopo Baussano; Miriam Elfström; Mehran Ghaderi; Penelope Gray; Katja Harjula; Kaisa Heikkilä; Mari Hokkanen; Saara Kares; Camilla Lagheden; Pekka Nieminen; Anna Söderlund‐Strand; Joakim Dillner; Ville N. Pimenoff
delete分享
delete收藏
Real‐World Experience With Multimodal Treatment of Resectable Stage II – III Non‐Small Cell Lung Cancer: A Single Institutional Analysis可切除II期–III期非小细胞肺癌的多模式治疗真实世界经验：一项单机构分析
deleteInternational Journal of Cancer
IF4.7
delete2026-10-14
delete0
deleteOAAI
deleteRaffaella Griffo; Benedikt Niedermaier; Laura V. Klotz; Marc Schneider; Michael Allgäuer; Marc Kriegsmann; Romina M. Roesch; Lena Brendel; Henrike Deissner; Farastuk Bozorgmehr; Petros Christopoulos; Michael Thomas; Hauke Winter; Martin E. Eichhorn; Florian Eichhorn
delete分享
delete收藏
Molecular and Clinicopathological Characteristics Predict Fertility‐Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrioid Endometrial Cancer分子和临床病理特征可预测子宫内膜不典型增生和子宫内膜样子宫内膜癌保留生育功能治疗的效果
deleteInternational Journal of Cancer
IF4.7
delete2026-10-13
delete0
deleteOAAI
deleteTianwei Xing; Kun Wei; Yangyang He; Jiaqi Yu; Xiaohan Wu; Hongwen Gao; Ping‐Li Sun
delete分享
delete收藏
Oral and Fecal Microbial Dysbiosis as Non‐Invasive Diagnostic Biomarkers for Gastrointestinal Cancers: A Systematic Review and Meta‐Analysis of Diagnostic Accuracy口腔和粪便微生物失调作为胃肠道癌的非侵入性诊断生物标志物：一项关于诊断准确性的系统评价和Meta分析
deleteInternational Journal of Cancer
IF4.7
delete2026-10-13
delete0
deleteOAAI
deleteSaidi Hu; Zhouyan Chen; Yanxia Li; Qingyan Liao; Mingdong Luo; Danyang Song; Hanyue Yu; Yuetong Gao; Shuanglong Yang; Siran Wan; Shunhong Zhang; Chenchen Luo; Lin‐Yong Zhao
delete分享
delete收藏
Comments on: Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting评论：根据TOPAZ-1研究入组标准评估顺铂、吉西他滨和度伐利尤单抗的治疗结局：一项真实世界环境下的全球性大规模分析
deleteInternational Journal of Cancer
IF4.7
delete2026-10-13
delete0
PREAI
deleteYu Zhang
delete分享
delete收藏
Familial Cancers Associated With Cancers of the Breast, Prostate, Colorectum, and Lung in Sweden瑞典乳腺癌、前列腺癌、结直肠癌和肺癌相关的家族性癌症
deleteInternational Journal of Cancer
IF4.7
delete2026-10-13
delete0
deleteOAAI
deleteFrantisek Zitricky; Kristina Sundquist; Jan Sundquist; Akseli Hemminki; Asta Försti; Kari Hemminki
delete分享
delete收藏
Reply to: Comments on “Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting”回复：《关于“根据TOPAZ-1研究入组标准评估顺铂、吉西他滨和度伐利尤单抗的疗效：一项大规模全球真实世界分析”的评论》
deleteInternational Journal of Cancer
IF4.7
delete2026-10-13
delete0
PREAI
deleteFederica Lo Prinzi; Margherita Rimini; Lorenzo Fornaro; Lorenza Rimassa; Andrea Casadei-Gardini
delete分享
delete收藏
Integrating Polygenic Risk Score, Sex, and Family History to Personalize the Initial Screening Age for Colorectal Cancer整合多基因风险评分、性别和家庭史以个性化结直肠癌初始筛查年龄
deleteInternational Journal of Cancer
IF4.7
delete2026-10-12
delete0
deleteOAAI
deleteWen Sun; Di Liu; Dongxue Wang; Jingyang Liu; Yujie Zhang; Fen Liu; Xiao Wang; Deqiang Zheng; Jianguang Ji
delete分享
delete收藏